In this USCAP 2025 symposium, Dr. Mahul Amin (LabCorp, Univ. of TN), Dr. Harshwardhan Thaker (UTMB) and Mariano de Socarraz (CorePlus) will provide an overview of the role AI is currently playing in the primary diagnosis of prostate cancer. New data will be presented from robust precision and clinical validation studies conducted at multiple US and European laboratories as part of the FDA clearance, demonstrating AI’s clinical utility and benefits compared with the current standard of care. Presenters will also share their digital pathology journeys and the benefits they are seeing from implementing AI-powered tools into routine clinical workflows in both private reference laboratories and academic medical centers.